Soft Tissue Allografts Market Outlook:
Soft Tissue Allografts Market size was over USD 5.04 Billion in 2025 and is anticipated to cross USD 9.2 Billion by 2035, growing at more than 6.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of soft tissue allografts is assessed at USD 5.32 Billion.
The growth of the market can be attributed to the increasing trauma cases related to accidents, sports injuries, and others. According to the data from 2021 from the Accident Compensation Corporation (ACC), there were roughly 692 million in injury claims related to sports and recreation. Moreover, according to the National Library of Medicine, 33 million skeletal injuries occur in the United States each year, of which 50% are tendon and ligament injuries.
In addition to these, factors that are believed to fuel the market growth of soft tissue allografts include the increasing count of anterior cruciate ligament (ACL) sprains and tears. Allograft tissue is the tissue that has been surgically implanted from one person to another. Soft tissue allografts are the replacement tissues used in an anterior cruciate ligament (ACL) to repair the damaged ligament, torn menisci, osteochondral defects, and spinal surgery. Utilization of allografts for soft tissue reconstruction results in less donor tissue site mortality and relatively short surgical time. For instance, in the United States, the prevalence rate of ACL sprains and tears ranges from 110,000 to 226,000 per year.
